Form 4: Director Terrance Williams Increases Encompass Health Stake

Director Terrance Williams acquired 27 restricted stock units in Encompass Health Corp via dividend reinvestment.

Summary

• Director Terrance Williams received 27 additional restricted stock units (RSUs) as part of a dividend reinvestment program.
• The transaction occurred on April 15, 2026, following a dividend payment of $0.19 per share.
• The total beneficial ownership for the director following this transaction is 15,196 shares of Encompass Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing with no impact on the company's strategic direction or financial health.

Positives

• Director maintains alignment with shareholders through continued equity accumulation.
• The acquisition reflects the automatic reinvestment of dividends, signaling confidence in the company's dividend policy.

Negatives

• None identified; this is a routine administrative transaction related to dividend payments.

Risks

• None identified; this is a standard equity compensation adjustment.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine RSU credits for directors are standard practice in the healthcare services sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for dividend reinvestment among S&P 400 companies.
• The use of RSUs for director compensation is consistent with peers such as HCA Healthcare and Universal Health Services.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard dividend reinvestment transaction.

Key Dates

Keywords

Encompass Health, EHC, Form 4, Insider Trading, Director Ownership, Dividend Reinvestment